Manufacturer record

Pharm Asia Drug: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Pharm Asia Drug (Madhya Pradesh) were declared Not of Standard Quality in February 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: FS-228A, Liquid Formaldehyde 40% w/v (Formallin) (exp Jul 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Methyl Alcohol & Assay of Formaldehyde 40%w/v. Listed in the February 2024 alert.

Records by type

2 records linked to Pharm Asia Drug in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2024 to Feb 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
2
Products affected
Assay
Most common failure
Feb 2024
Latest alert

Flagged batches per year

2024 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Liquid Formaldehyde 40% w/v (Formallin) Batch FS-228AMfg Aug 2022 · Exp Jul 2025 Methyl Alcohol & Assay of Formaldehyde 40%w/vAssay CDL KolkataCDSCO lab Feb 2024
Hydrogen Peroxide Topical Solution IP 6% w/v (20 Volume) Batch HP23-021Mfg Feb 2023 · Exp Jan 2025 Identification, Acidity, Non-volatile matter and Assay (Spurious)Assay CDL KolkataCDSCO lab Feb 2024

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid TabletsB95Y032SDTL, AssamThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Apr 2026
Trypsin-Chymotrypsin Tablets2KU6L055FDAL MaharashtraThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Jan 2026
Deflazacort Tablets 6 mg Defcort 613240334ARDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.